Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Lung
Published in: Lung 1/2008

01-02-2008

Gastroesophageal Reflux Disease and Chronic Cough

Author: Aaron Z. Tokayer

Published in: Lung | Special Issue 1/2008

Login to get access

Abstract

Gastroesophageal reflux disease (GERD) is a common cause of unexplained chronic cough. This article reviews important clinical considerations regarding association, diagnosis, and treatment of GERD in the setting of chronic unexplained cough.
Literature
1.
Spechler SJ (1992) Epidemiology and natural history of gastroesophageal reflux disease. Digestion 51(Suppl 1):24–29PubMedCrossRef
2.
Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1997) Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead County, Minnesota. Gastroenterology 112(5):1448–1456PubMedCrossRef
3.
Koufman JA (1991) The otolaryngologic manifestations of gastroesophageal reflux disease. A clinical investigation of 225 patients using ambulatory 24 hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101(4 Pt 2 Suppl 53):1–78PubMed
4.
Ing AJ, Ngu MC, Breslin AB (1994) Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 149(1):160–167PubMed
5.
Irwin RS, Richter JE (2000) Gastroesophageal reflux and chronic cough. Am J Gastroenterol 95(Suppl):S9–S14PubMedCrossRef
6.
Irwin RS (2006) Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines. Chest 129(1 Suppl):80S–94SPubMedCrossRef
7.
Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J (2005) Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54:449–454PubMedCrossRef
8.
Tutuian R, Mainie I, Agrawal A, Adams D, Castell DO (2006) Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 130(2):386–391PubMedCrossRef
9.
Ours TM, Kavuru MS, Schilz RJ, Richter JE (1999) A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 94:3131–3138PubMedCrossRef
10.
Prakash C, Jonnalagadda S (2006) Esophageal impedance testing: Unraveling the mysteries of gastroesophageal reflux. Gastroenterology 131(1):322–323PubMedCrossRef
Metadata
Title
Gastroesophageal Reflux Disease and Chronic Cough
Author
Aaron Z. Tokayer
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Lung / Issue Special Issue 1/2008
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9057-3

Other articles of this Special Issue 1/2008

Lung 1/2008 Go to the issue

OriginalPaper

Preclinical Assessment of Novel Therapeutics on the Cough Reflex: Cannabinoid Agonists as Potential Antitussives

OriginalPaper

Basic Mechanisms of Cough: Current Understanding and Remaining Questions

OriginalPaper

Before We Get Started: What Is a Cough?

OriginalPaper

The Current State of Cough Research: The Clinician’s Perspective

OriginalPaper

New Developments in the Objective Assessment of Cough

OriginalPaper

World Trade Center Cough Syndrome and Its Treatment
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits